Frequency and factors associated with delay in breast cancer treatment in Brazil, according to data from the Oncology Panel, 2019-2020

OBJECTIVE: to analyze treatment delay and the flow of care for women with breast cancer in Brazil in 2019 and 2020. METHOD: this was a follow-up study of breast cancer cases available from the Oncology Panel; a chi-square test and multilevel logistic regression were performed in order to analyze the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nogueira, Mário Círio, Atty, Adriana Tavares de Moraes, Tomazelli, Jeane, Jardim, Beatriz Cordeiro, Bustamante-Teixeira, Maria Teresa, Azevedo e Silva, Gulnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Secretaria de Vigilância em Saúde - Ministério da Saúde do Brasil 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027069/
https://www.ncbi.nlm.nih.gov/pubmed/36946833
http://dx.doi.org/10.1590/S2237-96222023000300004
Descripción
Sumario:OBJECTIVE: to analyze treatment delay and the flow of care for women with breast cancer in Brazil in 2019 and 2020. METHOD: this was a follow-up study of breast cancer cases available from the Oncology Panel; a chi-square test and multilevel logistic regression were performed in order to analyze the explanatory variables associated with delay (greater than 60 days) in starting treatment. RESULTS: 22,956 cases (54.5%) with delay in treatment were identified in 2019 and 17,722 (48.7%) in 2020; the Southeast region (54.6%) had the greatest proportion of delay; delay was greater when treatment was provided outside the municipality of residence and lower in 2020 compared to 2019; most outward flows were to the capital cities in the same Federative Units of residence. CONCLUSION: strategies to reduce cancer treatment delay and optimize health care networks in the Federative Units should be prioritized.

Ejemplares similares